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Abstract
Only a small percentage of human transcription factors (e.g. those associated with a specific differentiation program) are
expressed in a given cell type. Thus, cell fate is mainly determined by cell type-specific silencing of transcription factors that
drive different cellular lineages. Several histone modifications have been associated with gene silencing, including
H3K27me3 and H3K9me3. We have previously shown that genes for the two largest classes of mammalian transcription
factors are marked by distinct histone modifications; homeobox genes are marked by H3K27me3 and zinc finger genes are
marked by H3K9me3. Several histone methyltransferases (e.g. G9a and SETDB1) may be involved in mediating the H3K9me3
silencing mark. We have used ChIP-chip and ChIP-seq to demonstrate that SETDB1, but not G9a, is associated with regions
of the genome enriched for H3K9me3. One current model is that SETDB1 is recruited to specific genomic locations via
interaction with the corepressor TRIM28 (KAP1), which is in turn recruited to the genome via interaction with zinc finger
transcription factors that contain a Kruppel-associated box (KRAB) domain. However, specific KRAB-ZNFs that recruit TRIM28
(KAP1) and SETDB1 to the genome have not been identified. We now show that ZNF274 (a KRAB-ZNF that contains 5 C2H2
zinc finger domains), can interact with KAP1 both in vivo and in vitro and, using ChIP-seq, we show that ZNF274 binding
sites co-localize with SETDB1, KAP1, and H3K9me3 at the 39 ends of zinc finger genes. Knockdown of ZNF274 with siRNAs
reduced the levels of KAP1 and SETDB1 recruitment to the binding sites. These studies provide the first identification of a
KRAB domain-containing ZNF that is involved in recruitment of the KAP1 and SETDB1 to specific regions of the human
genome.
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Introduction
Transcription factors are key regulators involved in translating
genomic information into cellular and organismal phenotypes.
Previous studies have suggested that some transcription factors are
ubiquitously expressed (such as members of the E2F family);
presumably these factors regulate genes whose functions are
necessary for all cell types. However, a large number of
transcription factors are expressed in only a few specific tissues
(e.g. the testis-specific zinc finger protein ZBTB32); presumably
these factors regulate genes whose function must be limited to
those specific tissues [1]. Although only a small percentage of
human transcription factors have been well characterized,
previous studies suggest that it is critical that transcription factors
are properly controlled, being expressed only in the appropriate
cell type. For example, the inappropriate expression of certain
transcription factors has been clearly linked to human diseases
such as cancers and neurological and developmental disorders [1].
In pluripotent embryonic stem cells many genes involved in
creating specific differentiated cell types are kept at very low levels.
However, once a differentiation program has been induced, then
genes specific for a given cell state are turned on. Contained within
these sets of differentiation-responsive genes are tissue-specific
transcription factors. Our work [2,3] and other studies [4,5,6]
have revealed that epigenetic mechanisms (both DNA methylation
and histone modifications) are responsible for silencing cell type-
specific transcription factors in pluripotent cells.
Transcription factors are often classified according to their
DNA binding domains, which provide useful information
concerning their DNA binding patterns and their evolutionary
relatedness. It is estimated that there are ,1400 DNA binding
site-specific transcription factors in human cells [1,7,8,9]. Howev-
er, over 80% of the site-specific transcription factors encoded in
the human genome can be grouped into three categories; the
C2H2 zinc finger domain factors (675 genes), homeodomain
factors (257 genes), and helix–loop–helix factors (87 genes). We
have previously shown that the genes belonging to the two largest
groups of transcription factors are regulated by two different
epigenetic marks; in gene ontology analyses, the most enriched
class of transcription factor genes marked by H3K9me3 is C2H2
zinc finger transcription factors and the most enriched class of
transcription factor genes marked by H3K27me3 is homeodomain
transcription factors [2,3,10]. These results suggest that distinct
epigenetic regulatory complexes must be dedicated to controlling
expression of zinc finger vs. homeobox domain transcription
factors. We [10,11,12] and others [13,14], have shown that
components of Polycomb Repressive Complex 2 (PRC2) co-
localize with the H3K27me3 mark. However, the exact mecha-
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transcription factor genes is not known.
Initial studies of H3K27me3 and H3K9me3 using ChIP-chip
and promoter arrays identified large sets of promoters that were
distinguished by these two marks, often in a cell type-specific
pattern [3,10,14,15]. However, when studies were expanded to
ChIP-chip using genomic tiling arrays and then to genome-wide
ChIP-seq, it became clear that H3K27me3 and H3K9me3 were
not only found at promoter regions but that these marks could
also spread over larger genomic regions. For H3K27me3, the
spreading patterns are generally found over entire HOX gene
clusters, including coding, intragenic, and intergenic reigons [10].
The H3K9me3 mark can also spread over large regions, such as
centromeres, transposons, and tandem repeats [16,17,18]. In
addition, we have previously shown that the 39 exons of many
zinc finger genes (ZNFs) are specifically covered by H3K9me3
[3]. Other studies in progress are focused on determining whether
the 39 exons of ZNF genes correspond to alternative promoters.
However, the goal of this current study is to identify the DNA
binding factor that recruits a regulatory histone methyltransferase
to the 39 ends of the C2H2 zinc finger genes. To achieve this
goal, it is necessary to first identify the histone methyltransferase
that colocalizes with H3K9me3 at zinc finger genes, then to
identify a DNA binding factor that colocalizes with the histone
methyltransferase, and then finally to demonstrate that the
identified DNA binding factor is involved in recruitment of the
histone methyltransferase to 39 exons of ZNF genes. Several
histone methyltransferases have been implicated in methylation
of lysine 9 of histone H3, including G9a and SETDB1 [19]. We
investigate the role of these two histone methyltransferases in
regulating the H3K9me3 mark using genome-scale ChIP-chip
and ChIP-seq. Our studies demonstrate that SETDB1, but not
G9a, overlaps with H3K9me3 in K562 cells. We go on to test the
model that SETDB1 is recruited to specific genomic locations via
interaction with the corepressor TRIM28 (KAP1), which is in
turn recruited to the genome via interaction with zinc finger
transcription factors that contain a Kruppel-associated box
(KRAB) domain. Finally, we identify a KRAB-ZNF transcription
factor that co-localizes with H3K9me3 on C2H2 zinc finger
clusters in several different cell types and show that this DNA
binding factor is involved in targeting epigenetic regulatory
complexes to the human genome.
Results
SETDB1, but not G9a, correlates with H3K9me3 genomic
localization patterns
As a first step toward understanding the mechanisms by which
zinc finger transcription factor genes are marked by H3K9me3, we
wished to identify the responsible histone methylase; possible
candidates included G9a/KMT1C, GLP/KMT1D, SETDB1/
KMT1E, Suv39h1/KMT1A and Suv39h2/KMT1B [20,21,22,23,
24,25,26]. We used antibodies that recognize H3K9me3, G9a, or
SETDB1 and performed ChIP-chip (chromatin immunoprecipita-
tion followed by hybridization to oligonucleotide arrays) assays to
compare the bindingpatterns of G9a and SETDB1 with the pattern
of H3K9me3 (we note that we have not been able to obtain robust
enrichments in ChIP assays using antibodies to other H3K9
methylases such as Suv39h1/KMT1A or Suv39h2/KMT1B). The
majority of C2H2 zinc finger genes reside on chromosome 19,
having expanded into large clusters of highly related genes at several
evolutionary stages, including at the appearance of vertebrates and
again substantially during the emergence of mammals and primates
[27]. Therefore, we began our studies by performing ChIP-chip
using arrays that include the entirety of chromosome 19. ChIP
samples were obtained using K562 cells, amplified, and applied to
the genomic tiling arrays. We identified many binding sites for the
histone methyltransferase G9a (see Supplementary Figure S1
for examples of G9a peaks). However, G9a does not bind to the
same regions of the genome as are covered by the H3K9me3 mark
(Figure 1). The peaks that were observed confirmed to be true G9a
binding sites, as determined by PCR analysis of subsequent ChIP
assays (see Supplementary Figure S1) and by the fact that they
localized to sites bound by H3K9me2, not H3K9me3 (H. O’Geen,
unpublished data). In contrast, the binding pattern of the histone
methyltransferase SETDB1 showed a large overlap with the
H3K9me3 marks (Figure 1A). One current model in the field is
that SETDB1 is brought to the DNA via interaction with the
TRIM28 (also known as KAP1) corepressor [20]. Therefore, we
also performed ChIP-chip with an antibody to KAP1 and showed
that both KAP1 and SETDB1 were bound to the same genomic
locations. We next wished to compare the overlap of all target sites
for H3K9me3 with the SETDB1 and KAP1 peaks. However,
because the H3K9me3 binding pattern has many very broad
regions, standard peak-calling programs are not appropriate.
Therefore, we developed a modified version of our Tamalpais
ChIP-chip peak calling program [28] that smoothes oligonucleotide
intensities usinga sliding average,andallowsgapscausedbymissing
oligonucleotides (the result of the repetitive nature of H3K9me3
target regions); see methods for more details concerning the
Mayacamas peak-calling program). Using the Mayacamas pro-
gram, we identified 1487 target regions for H3K9me3, 566 target
sites for SETDB1, 496 target sites for KAP1 and 172 target sites for
G9a on chromosome 19. We found that most of the SETDB1 and
KAP1 sites on chromosome 19 were also sites for H3K9me3, but
that very few G9a sites were located in regions covered by
H3K9me3 (Figure 1B). A list of all the ChIP-chip arrays can be
found in Supplementary Table S1 and the chromosome 19
genomic regions bound by KAP1, SETDB1, G9a, and H3K9me3
can be found in Supplementary Table S2.
The ChIP-chip experiments suggested a general relationship
between H3K9me3 and SETDB1. However, these analyses were
not genome-wide. The advent of the ChIP-seq technology now
allows for a more economical and precise mapping of chromatin
patterns throughout the human genome and therefore we next
performed ChIP-seq experiments for H3K9me3, SETDB1, and
KAP1 in K562 cells (see Supplementary Table S1 for a
summary of the ChIP-seq samples analyzed in this study). As with
the ChIP-chip data, analysis of chromatin patterns from ChIP-seq
data required modification of our standard peak-calling program,
Sole-search [29]. Therefore, we adapted Sole-search to call
broader peaks (for more details see Methods) and then identified
3866 target regions for H3K9me3, 302 sites for SETDB1, and 155
sites for KAP1 on chromosome 19. Comparison of peak sets
identified using ChIP-chip and ChIP-seq for H3K9me3,
SETDB1, and KAP1 and a comparison of the binding patterns
for H3K9me3, SETDB1, and KAP1 using the different platforms
is shown in Supplementary Figure S6.
ZNF274 co-localizes with the KAP1 and SETDB1
Although it is clear that KAP1 and SETDB1 co-localize with
H3K9me3, neither of these two proteins has a specific DNA
binding domain and therefore additional factors are required to
recruit the complex to specific regions of the genome. KAP1
contains an N-terminal protein interaction domain (the RBBC
domain) that can interact in vitro with a KRAB domain [30,31].
KRAB domains are found in a variety of different proteins
[32,33,34], but the most prevalent set of KRAB domain
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transcription factors (ZNFs); approximately 300 C2H2 ZNFs
contain a KRAB domain [35,36]. Most of the previous studies of
KRAB domains have been performed by artificially tethering an
isolated KRAB domain to the chromatin using transiently
introduced or stably integrated artificial reporter constructs
[37,38,39]. To date there have been no studies that have shown
similar cellular binding patterns of a KRAB domain containing
protein and H3K9me3. In fact, the only genome-wide ChIP-seq
analysis of a KRAB-ZNF showed that there was essentially no
overlap between the ,5,000 ZNF263 binding sites and the
H3K9me3 chromatin pattern [40]. Therefore, it is not known
which site-specific factor(s) is involved in recruiting the KAP1/
SETDB1 epigenetic regulatory complex to the genome under
normal physiological conditions.
In general, KRAB-ZNFs are expressed at low levels and many
are tissue-specific [33]. We therefore obtained antibodies to
numerous KRAB-ZNFs (more than 25 different antibodies were
tested), performed western blots to identify KRAB-ZNFs that
were expressed in K562 cells, and then performed immunopre-
cipitation experiments to determine if the antibodies for the
expressed factors would potentially work in ChIP assays. Finally,
we performed ChIP-seq analysis using antibodies to ZNF14,
ZNF180, ZNF195, ZNF212, ZNF689, and ZNF274. Of these,
the only one that showed binding to the genome was ZNF274.
Therefore, we focused our analyses on this KRAB-ZNF. As
shown in Supplementary Figure S2, we found that ZNF274
is expressed in GM12878, HepG2, HeLa, and K562 cells.
ZNF274 contains 5 DNA binding zinc finger domains, a protein-
protein interaction SCAN domain, and 2 KRAB domains. A
published study demonstrated that ZNF274 KRAB domains
could repress transcription of a synthetic promoter construct
when fused to the Gal4 DNA binding domain [41]. Although the
previous work did not determine if the repression mediated by a
GAL4-ZNF274 KRAB domain fusion protein involved KAP1, it
did suggest that perhaps ZNF274 would be a good candidate for
further analyses.
To determine whether the KRAB domains of ZNF274 could
recruit KAP1, we first used an in vitro system. We used the ZNF10
KRAB domain as a positive control because the KRAB domain of
this factor has been shown to interact with KAP1 in vitro [31];
unfortunately, we could not detect this protein by western blot
using a series of commercially available antibodies (data not
shown) and therefore we could not test if ZNF10 recruits the
KAP1/SETDB1 complex in cells. We used the ZNF263 KRAB
domain as a negative control, because we have previously shown
that it does not co-localize with the KAP1/SETDB1 complex
[40]. Portions of these two ZNFs (Figure 2A) corresponding to the
KRAB domains were generated as recombinant GST fusion
proteins and were incubated with nuclear extract from K562 cells.
Figure 1. SETDB1, but not G9a, colocalizes with H3K9me3 on chromosome 19. (A) ChIP-chip binding patterns of KAP1, SETDB1, H3me3K9
and G9a are compared at a zinc finger gene cluster on chromosome 19. The log2 (ratio) values reflecting the ChIP enrichments are plotted on the y
axes and chromosomal coordinates are shown on the x axis. (B) Peaks were called using the ChIP-chip array data for SETDB1, G9a, and KAP1 using the
Mayacamas peak calling program. The total number of peaks for each data set are shown; the intersection indicates the number of SETDB1, KAP1,
and G9a peaks that overlap with the H3K9me3 peaks.
doi:10.1371/journal.pone.0015082.g001
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using antibodies to KAP1. As shown in Figure 2C, the KRAB
domain of ZNF10, but not of ZNF263, can precipitate KAP1. We
next tested the two KRAB domains present in ZNF274 and found
that regions containing either of the KRAB domains of ZNF274
(amino acids 2-90 and 278-366) could interact with KAP1 in vitro,
although the more N-terminal KRAB domain of ZNF274
appeared to have higher affinity for KAP1. A sequence alignment
(Figure 2B) demonstrates that the first KRAB domain of ZNF274
is virtually identical to a KRAB domain consensus sequence
derived from an alignment of the KRAB domains from 10
independent zinc finger gene products [30]. The KRAB domain
of ZNF263, however, has substitutions in amino acids corre-
sponding to critical residues in the KRAB domain consensus
sequence, including the MLE sequence that occurs in the context
of the highly conserved VMLENY motif common to many KRAB
A boxes and critical for repression. This leucine residue is one of
the heptad repeats of leucines (MX6LX6LX6L, where X is any
amino acid) capable of forming an amphipathic helix [30]. The
lack of the hydrophobic interaction domain may explain the
inability of ZNF263 to interact with KAP1 in this assay. These
biochemical experiments emphasize the need to check each
KRAB-ZNF for interaction with KAP1; simply having a KRAB
domain does not necessarily ensure interaction with KAP1. The
second KRAB domain of ZNF274 contains the MLE sequence but
lacks a leucine residue in the A box helical region as well as leucine
residues in the B box, possibly explaining its weaker association
with KAP1 compared to the first ZNF274 KRAB domain. To
confirm the interaction between KAP1 and ZNF274 we
performed co-immunoprecipitation experiments in K562 whole
cell extracts using antibodies against endogenous proteins. These
experiments demonstrated that endogenous ZNF274 specifically
co-precipitates with KAP1 and SETDB1 but not with G9a or
control IgG (Figure 2D). Similarly, ZNF274 co-precipitated both
KAP1 and SETDB1 but not G9a (lane 4). Together, these data
suggest that KAP1/SETDB1 associate with ZNF274 in vivo. It
should be noted that we failed to detect sufficient levels of
SETDB1 in KAP1 immunoprecipitation reactions, and vice versa
(lanes 3 and 5, respectively). Also, despite significant co-precipitation
of SETDB1 with G9a immunoprecipitations, we failed to detect
Figure 2. A KRAB-domain containing protein ZNF274 interacts with the KAP1 corepressor both in vitro and in vivo. A) Schematics of
ZNF263 and ZNF274 proteins are shown, indicating the position of the KRAB domains (potential KAP1-interacting domains), the SCAN domains, and
the zinc fingers (DNA binding domains). B) The KRAB domains of ZNF274, ZNF263, and ZNF10 are compared at the amino acid level. C) Purified KRAB-
GST fusion proteins are shown in the bottom panel. In the top panel, nuclear proteins from K562 cells that bound to the indicated KRAB-GST fusion
proteins were analyzed using an antibody to KAP1. D) Co-immunoprecipitation of endogeneous ZNF274 with KAP1 and SETDB1, but not with G9a.
Control IgG, KAP1, ZNF274, SETDB1, and G9a antibodies were used in immunoprecipitation reactions using K562 cell extracts and were analyzed by
western blotting using the indicated antibodies.
doi:10.1371/journal.pone.0015082.g002
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6). Nevertheless, we conclude that ZNF274 can interact with
KAP1 and SETDB1 in cells.
Having shown that ZNF274 interacts with KAP1 in vitro and in
vivo, the next step was to determine if ZNF274 co-localizes with
KAP1 on the genome. Because there are no known binding sites
for ZNF274, we could not test the quality of the ChIP or the
library before proceeding to ChIP-seq experiments. However, we
did show that the ZNF274 antibody was capable of immunopre-
cipitating ZNF274 protein from nuclear extract (Supplementary
Figure S2B). We performed two ChIP assays using K562 cells
grown on separate days, made and sequenced libraries, and called
peaks using Sole-search [29]. We obtained 7,654,486 uniquely
mapping tags (i.e. tags that map to only one place in the human
genome) for replicate 1 and 11,341,812 uniquely mapping tags for
replicate 2. However, the number of peaks identified for each
replicate was fairly small; 192 peaks for replicate 1 and 273 peaks
for replicate 2. To determine the quality of the ChIP-seq data, we
used the ENCODE overlap standards. Briefly, we compared the
top 40% of the peaks in one replicate to the entire set of peaks
(after truncating the peak lists to the same length) in the other
replicate. We found a 95 and 100% overlap for the 2 comparisons,
indicating that the called peaks were essentially identical in the two
replicates. We then merged the uniquely mapping tags from both
sequence runs and called peaks on the merged dataset to obtain a
final number of 337 peaks. Because this was a very small number
of binding sites (most factors that we have tested by ChIP-seq have
between 1,000 and 30,000 binding sites; Frietze, O’Geen, Xu, and
Farnham, unpublished data), we also performed ChIP-seq for
ZNF274 in 3 other cell types. We identified 469 binding sites in
HepG2 cells, 336 binding sites in GM12878 cells, and 220 binding
sites in HeLa cells (see Table 1 for a detailed characterization of
all peaks called in the ChIP-seq experiments). Although the
number of ZNF274 peaks was small for each cell type, the sets of
peaks were similar in all cells; see Figure 3 for a comparison of
ZNF274 binding in 4 different cell types and Supplementary
Table S3 for a list of the ZNF274 peaks identified in K562,
HeLa, HepG2, and GM12878 cells.
We performed follow-up analyses of the ZNF274 binding sites
from K562 cells using the Sole-search location analysis tool kit
[29]; see also http://chipseq.genomecenter.ucdavis.edu/cgi-bin/
chipseq.cgi. As shown in Figure 4A, the majority of the binding
sites for ZNF274 are on chromosome 19. As mentioned above,
most C2H2 zinc finger genes are located on chromosome 19,
suggesting that ZNF274 may in fact be involved in recruiting the
SETDB1 histone methyltransferase to the family of C2H2 zinc
finger genes. A comparison of the ZNF274, SETDB1, and KAP1
peak sets is shown in Figure 4C whereas ChIP-seq binding
patterns of ZNF274, KAP1, SETDB1, and H3K9me3 throughout
the entire chromosome 19 are shown in Figure 4D (also see
Supplementary Figure S9 for views of individual binding sites).
The strong similarity in the binding patterns suggest that ZNF274
does in fact bind to C2H2 zinc finger genes; accordingly, a gene
ontology analysis of the genes bound by ZNF274 shows that
KRAB and SCAN domain containing zinc finger genes are
essentially the only enriched category of genes (Figure 4B).
ZNF274 binding to the 39 ends of ZNF genes was confirmed using
ChIP-qPCR (Figure 5A).
Co-occupancy of ZNF274, KAP1 and SETDB1 at ZNF 39
ends in vivo
The observation that ZNF274 binds to the 39 ends of certain
ZNF gene targets also bound by KAP1 and SETDB1 in K562 cells
does not indicate whether these factors are simultaneously bound
at the same loci. We therefore used sequential chromatin
immunoprecipitation to determine co-occupancy of ZNF274 with
KAP1 or SETDB1 at the 39 ends of ZNF genes in vivo. Specifically,
we first performed ChIPs with antibodies for one factor (i.e.
ZNF274 or KAP1), eluted the protein-DNA complexes and then
immunoprecipitated the resulting sample with antibodies for the
other factor (i.e. ZNF274, KAP1, SETDB1, or control IgG). We
tested the eluates of sequential ChIP reactions by PCR using
primers to the ZNF274 binding site ZNF180 and to control
ZNF555 and STX16 binding sites. Using this assay, co-occupancy
of ZNF274 and KAP1 at ZNF180 was observed when the first
ChIP was performed with ZNF274 followed by KAP1 (Figure 5B,
lane 3). In the reciprocal experiment in which KAP1-bound targets
were immunoprecipitated first, ZNF180 shows specific enrichment
upon subsequent immunoprecipitation with ZNF274 antibodies
but not with control IgG (lanes 6 and 5, respectively). Similarly, when
ZNF274 or KAP1 ChIPs were sequentially immunoprecipitated
with SETDB1 antibodies, there is specific enrichment of the
ZNF180 binding site (lanes 4 and 7, respectively). Conversely, the
control ZNF555 or STX16 binding sites are not enriched in any of
the ZNF274 ChIPs. The ZNF555 binding site is specifically
enriched when KAP1 ChIPs were followed by SETDB1, but not
by ZNF274 or control IgG sequential immunoprecipitations (lanes
7, 6 and 5, respectively). Therefore, we conclude that ZNF274, KAP1
and SETDB1 co-occupy the ZNF180 39 end binding site in vivo.
Characterization of ZNF274 binding sites
We next performed a series of additional characterizations of
the ZNF274 binding sites. First, we determined the expression
Table 1. Summary of ChIP-seq data.
Dataset/cell type
SETDB1/
K562
KAP1/
K562
H3K9me3/
K562
ZNF274/
K562
ZNF274/
HepG2
ZNF274/
GM12878
ZNF274/
HeLa
Number of peaks: 3,238 3,085 16246 337 469 336 220
Average peak height: 27 30.07 18.14 49 42 43 38
Median peak height: 25 25 16 34 29 31 33
Highest peak: 102 185 141 195 195 166 117
Lowest peak: 14 16 14 17 16 15 16
Average peak width: 547 385.16 1151.44 649 551.86 604.62 469
# uniquely mapped reads 21,434,178 26,458,932 43,691,075 18,856,543 22,363,343 10,487,897 18,852,757
Numbers are from the analysis of two merged replicate datasets.
doi:10.1371/journal.pone.0015082.t001
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details). Analysis of this set of genes showed that they were
expressed at low levels, in comparison to the analysis of the K562
cell transcriptome (Supplementary Figure S7). We also
compared the set of C2H2 zinc finger genes that were bound by
ZNF274 to the entire set of 712 C2H2 zinc finger genes encoded
in the human genome. As shown in Figure 6, most C2H2 zinc
finger genes bound by ZNF274 contain between 9 and 19 finger
domains, as opposed to the overall set of C2H2 zinc finger genes
which consists of a large number of genes having 1-6 finger
domains and another large set of genes having 7-12 finger
domains. We also note that although there are very few C2H2
genes encoded in the human genome that have more than 25
finger domains (96 of the 712 C2H2 genes), 43% of these are
bound by ZNF274.
As indicated above, no binding sites had previously been
identified for ZNF274 prior to our ChIP-seq studies. Therefore,
we wished to determine whether a ZNF274 consensus motif could
be identified from the ChIP-seq data. We analyzed 50 nt on each
side of the midpoint of the 337 ZNF274 peaks from K562 cells.
We chose this range because other studies have shown that a
known consensus motif for a factor can be found in 75% of the
peaks if ,50 nucleotides from the center of the peak is used for
analysis [42]. Motif finding for ZNF274 is complicated by the fact
that the binding sites are contained with the final coding exon of
the C2H2 target genes. All C2H2 target genes contain multiple
zinc finger domains and conserved linker motifs between each
finger. Therefore, many conserved motifs would be identified in
the set of ZNF274 targets that would essentially correspond to
coding sequences if standard backgrounds were used. Therefore,
we used as our background a set of 39 exons from C2H2 zinc
finger genes NOT bound by ZNF274. Using our W-ChIPsmotifs
program [43,44], we identified a number of motifs that were
highly enriched in the ZNF274 binding sites but not in the control
set of C2H2 39 exons (Supplementary Table S4). ZNF274
contains 5 zinc fingers and if each finger contacted 3 nucleotides of
DNA the motif would be expected to be 15 residues in length.
However, it is not known if all fingers in multi-finger DNA binding
factors contact DNA. Also, we do not know if ZNF274 works as a
monomer, as a homodimer, or as a heterodimer with another
factor. In support of the possibility that ZNF274 may use different
sets of fingers to bind to different motifs, we identified several
different motifs that were highly enriched in the ZNF274 binding
sites. A list of the entire set of enriched motifs along with the
position weight matrices is shown in Supplementary Figure
S4, and similarity of each enriched motif to the closest known
motif for other factors is shown in Supplementary Figure S5.
We note the ZNF274 motifs do not have high similarity to binding
sites of other factors, but we did identify several quite long motifs.
As shown in Figure S8, we found 210 copies of the M1 motif and
199 copies of the M11 motif in the set of 337 ZNF274 K562 peaks.
We searched the entire human genome using the M11 and M1
PWMs and found that at the highest stringency (1.00/0.99), there
are only 724 matches to the M1 PWM and 190 matches to the
M11 PWM in the entire genome; at a lower stringency (1.00/
0.95), there are 1198 matches to the M1 PWM and 703 matches
to the M11 PWM (Supplementary Table S6). Thus, the ,200
copies of these motifs found in the 337 ZNF274 peaks represents a
significant fraction of the motifs encoded in the human genome.
Finally, we performed a location analysis of the M1 and M11
matches in the human genome and found that 80% of the matches
were at ZNF genes; for M1: 569 of 724 top matches and 968 of
1198 lower stringency matches; for M11: 148 of 190 top matches
and 571 of 703 lower stringency matches. Thus, the M1 and M11
motifs are essentially only found in or near ZNF genes.
Although the entire set of ZNF274 binding sites were used for
the motif analysis, the two long motifs shown in Figure S8, panel
A are highly enriched in the top 100 ranked peaks. In fact, both
motifs are present in 72 of the top100 ranked ZNF274 binding
sites. This motif enrichment is similar to the enrichment of motifs
under ChIP-seq peaks for other well-characterized factors [42].
The fact that both motifs are often found in the same binding site
lead us to examine the relationship of the two motifs. We found
that the 39 end of M11 is identical to the 59 end of the reverse
Figure 3. ZNF274 binds to C2H2 zinc finger genes. ChIP-seq binding patterns of ZNF274 from GM12878, HeLa, HepG2, and K562 cells are
compared to the location of all C2H2 zinc finger genes on chromosome 19. The number of tags reflecting the ChIP enrichments are plotted on the y
axes and chromosomal coordinates are shown on the x axis.
doi:10.1371/journal.pone.0015082.g003
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fact constitute a single long motif in a large number of the ZNF274
binding sites (see Figure S8, panel C and Figure S10).
Interestingly, the 29 mer encodes the linker and conserved H2
helix that are found in C2H2 ZNFs (Figure S8, panel D). It is
important to note that not all C2H2 zinc fingers contain the 29mer
(we used C2H2 zinc fingers that are not bound by ZNF274 as our
background model to identify the M1 and M11 motifs; see also
Figure S10). Sequence analysis indicates that the C2H2 ZNFs
that do not contain the 29mer use different nucleotides to encode
their linker and H2 helix.
ZNF274 recruits the KAP1/SETDB1 epigenetic regulatory
complex to the human genome
Based on the similar binding patterns of ZNF274, KAP1, and
SETDB1 and a current model in the field that a KRAB-ZNF
recruits SETDB1 and KAP1 to the genome (Figure 7), we
hypothesized that ZNF274 is a site-specific factor that recruits the
SETDB1 histone methyltransferase to specific regions of the
genome. To test this hypothesis, we knocked down the levels of
ZNF274 using transfection of siRNAs. As shown in Figure 8A,
protein levels of ZNF274 were reduced when siRNAs specific to
ZNF274 mRNA were introduced into cells. To determine the
effects of loss of ZNF274, we performed ChIP analysis on two
ZNF274 binding sites (ZNF180 and ZNF554) and on two ZNFs that
arenotZNF274bindingsites(ZNF555andZNF556);seeFigure8B
for binding profiles of KAP1, SETDB1, ZNF274, and H3K9me3
for ZNF554 (a ZNF274 binding site) vs. ZNF556 (not a ZNF274
binding site). We found that introduction of siRNAs to ZNF274
reduced the ZNF274 ChIP signal at the two binding sites but did
not affect the extremely low signals at the non targets ZNF555 and
ZNF556 (Figure 8C). The KAP1, SETDB1 and H3K9me3 signals
were also reduced at ZNF180 and ZNF554, but not at ZNF555 or
ZNF556. These results are consistent with the hypothesis that, at
specific sites, ZNF274 recruits KAP1, which recruits SETDB1,
which results in trimethylation of histone H3 on lysine 9.
Discussion
The H3K9me3 methylome
We have previously shown that homeobox genes are bound by
H3K27me3 whereas the 39 regions of zinc finger genes are bound
Figure 4. ZNF274 binds specifically to ZNF genes. A) The number of ZNF274 binding sites in K562 cells is shown for each chromosome (solid
line). Also shown is the number of C2H2 ZNF genes encoded on each chromosome (dotted line). B) The ZNF274 target genes in K562 cells were
analyzed using the DAVID gene ontology program. Shown are the enriched terms and P-value of enrichments of the target genes. C) Overlaps of the
peaks sets of ZNF274, SETDB1, and KAP1 are shown; 85% of the 337 ZNF274 peaks, 52% of the 3237 SETDB1 peaks, and 54% of the 2027 KAP1 peaks
overlap with H3K9me3. D) The ChIP-seq binding patterns of ZNF274, KAP1, SETDB1, and H3me3K9 are compared on chromosome 19. The number of
tags reflecting the ChIP enrichments are plotted on the y axes and chromosomal coordinates are shown on the x axis.
doi:10.1371/journal.pone.0015082.g004
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determine the mechanism by which a H3K9me3-specific histone
methyltransferase is recruited to the 39 ends of C2H2 zinc finger
genes. To achieve this goal, we first demonstrated that SETDB1
colocalizes with H3K9me3 at zinc finger genes, then we identified
ZNF274 as a DNA binding factor that can recruit the KAP1/
SETDB1 histone methyltransferase complex to the 39 ends of
certain zinc finger genes. Thus, ZNF274 is a critical component of
this epigenetic complex in a variety of cell types. However, KAP1
and SETDB1 are recruited to additional zinc finger genes than are
not bound by ZNF274 (see Figure 8B), indicating that at least one
other factor (likely a KRAB-ZNF protein) must be involved with
recruitment of KAP1/SETDB1 to H3K9me3 sites. We have also
shown that H3K9me3 is found at a large number of sites that are
devoid of KAP1 and SETDB1. However, one must keep in mind
the fact that H3K9me3 displays a spreading, not a peak-like, ChIP-
seq pattern at many sites. It is possible that a single recruitment of
SETDB1 could result in the methyation of several nucleosomes on
either side of a binding site. To test this hypothesis, we plotted the
position of the top 10% (3047 peaks) of the H3K9me3 sites relative
to the center of the peak of the 3238 SETDB1 peaks. As shown in
Figure 9B, mostof the strongest H3K9me3 sites are located within
1-2 kb of a SETDB1 site, indicating that SETDB1 is an important
contributor to the H3K9me3 regulome. However, we note that
there are regions of the genome that show large coverage by
H3K9me3 but no SETDB1 binding (Figure 9C). Thus, the
H3K9me3 regulome must be defined by both SETDB1 and
another, as yet unidentified, histone methyltransferase (Figure 9A).
Other candidate histone methyltransferases include G9a/KMT1C,
GLP/KMT1D, Suv39h1/KMT1A and Suv39h2/KMT1B [21,22,
23,24,25,26]. Our analysis of the binding patterns of G9a suggest
that it is not involved in H3K9me3 formation on chromosome 19.
Our findings aresupported by previous studies linking G9ato mono
and dimethylation (but not trimethylation) of lysine 9 of histone H3
[45,46]. However, we also note that other studies have shown that
reduction of G9a can have modest effects on global H3K9me3
levels [47]. Also, a recent study has shown that a subset of G9a/
KMT1C, GLP/KMT1D, Suv39h1/KMT1A and SETDB1/
KMT1E exist in a large complex and that reduction of G9a can
result in a reduction of H3K9me3 at certain locations [48]. Perhaps
the regions (e.g. centromeres or repetitive elements) at which G9a
modulates H3K9me3 are not easily studied by ChIP-chip and/or
they are not located on chromosome 19. We have not been
successful in enriching for H3K9me3-bound regions using a variety
of commercially available antibodies to Suv39h1/KMT1A or
Suv39h2/KMT1B (data not shown), but it is not possible to draw
conclusions from negative results because the antibodies may not
have been of high enough affinity for these experiments.
As one way of addressing whether there are distinct subsets of
H3K9me3-bound regions, we performed gene ontology analyses.
We divided the H3K9me3 sites into sets bound by H3K9me3 and
SETDB1 vs. sets bound by H3K9me3 but not by SETDB1. Using
the Database for Annotation, Visualization and Integrated
Discovery (DAVID) [49,50], we first performed a gene ontology
analysis of the sites bound by both H3K9me3 and SETDB1. As
expected, based on our previous studies [2,3,10], we found a
striking enrichment of gene categories related to transcription and
DNA binding. In contrast, when we analyzed the sites bound by
H3K9me3 but not by SETDB1, we observed enrichment in
numerous different functional categories including genes involved
in signaling through phosphorylation, amino acid transport, cell
adhesion, metabolism and development (using a p-value ,1e-3;
see Supplementary Table S6). These annotations imply broad
functions for H3K9me3 and are consistent with reports that
H3K9me3 is present across a wide range of genes [51,52] and that
it may be involved in global organization rather than a direct role
in gene regulation [53]. Our studies highlight the concept that
specific subsets of H3K9 trimethylated regions exist across the
genome and support a specific role for SETDB1 in altering the
chromatin structure of zinc finger transcription factor genes
through H3K9 methylation.
We also note that a recent paper has implicated SETDB1 in
maintenance of the mouse ES cell pluripotent state [54]. In that
study, SETDB1 was found mainly at promoters of genes involved
Figure 5. Co-occupancy of ZNF274, KAP1 and SETDB1 at a ZNF
39 end in vivo. A) ChIP-qPCR confirmation of a set of ZNF274 targets.
Quantitative real-time PCR (qPCR) for 10 target regions identified by
ChIP-seq and three negative regions (GAPDH, CDH1, and ZNF44) was
performed. The fold enrichment of each site was calculated as 2 to the
power of the cycle threshold (cT) difference between input chromatin
and ChIP samples. The results in the graph are the mean of three
independent replicates with standard deviation. Primers used in these
experiments can be found in Supplementary Table S5. B) Sequential
chromatin immunoprecipitation of ZNF274 and KAP1 in K562 cells.
ZNF274 or KAP1 ChIP samples were sequentially immunoprecipitated
using the indicated antibodies. The samples were analyzed by PCR and
agarose gel electrophoresis with ethidium bromide staining using
specific primer sets to ZNF180, a zinc finger gene bound by ZNF274;
ZNF555, a zinc finger gene not bound by ZNF274, but bound by KAP1;
STX16, and a non-zinc finger gene bound by neither ZNF274 nor KAP1.
doi:10.1371/journal.pone.0015082.g005
ZNF274 Recruits SETDB1 to the 3’ Ends of ZNF Genes
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15082in developmental regulation and many of those promoter regions
were also occupied by H3K9me3, H3K27me3, and SUZ12.
These results are in direct contrast with our studies showing that
SETDB1 binding sites are the 39 ends of ZNF genes (not
promoters) and that they correlate with H3K9me3 but not
H3K27me3. Additionally, we find no binding of SUZ12 to
SETDB1 binding sites in K562 cells (data not shown). These
results suggest that SETDB1 plays a unique role in the more
differentiated human K562 cells as compared to its role in
pluripotent mouse ES cells.
Specificity of binding of ZNF274
As indicated above, ZNF274 is specifically targeted to 39 ends of
a subset of ZNF genes. In fact, the few binding sites that have a
‘‘nearest’’ gene that is not a ZNF, such as the site located in intron
4 of the MAPK9 gene, are actually evolutionary remnants of ZNF
genes (as determined by DNA sequence similarity identified using
BLAT). However, not all ZNF 39 ends are bound by ZNF274.
Although one could certainly imagine chromosomal positioning
influencing accessibility of ZNF274 to binding sites, there are
many examples where ZNF274 binds to the 39 end of one ZNF in
a cluster but not to the neighboring ZNFs. For example, the
nearest neighbors to the ZNF554 39 end (which is bound by
ZNF274) are ZNF555 and ZNF556. However, the ZNF555 and
ZNF556 39 exons are bound by KAP1 and SETDB1 but not by
ZNF274. Thus, there must be some degree of specificity to the
binding of ZNF274. Using the prediction method described in
Pabo et al. [55], the zinc finger code predicts a fairly non-specific
binding site for ZNF274 of 59NGAGGAANCANANNN39 or the
complement 59NNNTNTGNTTCCTCN39 (DJ Segal, unpub-
lished information). However, these sites are not similar to the
motifs identified in the ChIP-seq identified regions. It remains to
be determined exactly how specificity of binding is achieved by
ZNF274 but possibilities include heterodimerization with another
protein or selective use of a subset of the zinc fingers.
Conclusion
Our studies have provided the first support for the working
model that an endogenous KRAB-ZNF (ZNF274) can, within a
cellular environment, recruit the KAP1/SETDB1 histone meth-
yltransferase complex to the genome and that these sites
correspond to sites of H3K9me3. However, because ZNF274
does not bind to all ZNF 39 ends, our studies also clearly suggest
that additional KRAB-ZNFs contribute to the formation of the
H3K9me3 methylome. Future ChIP-seq studies of additional
candidate KRAB-ZNFs as well as mass spectrometry to identify
additional SETDB1 partners are required to identify the set of
KRAB-ZNFs involved in H3K9me3 pattern formation. Finally,
we are continuing to investigate H3K9me3 sites that are not
bound by KAP1/SETDB1 with the goal of identifying other
involved histone methyltransferases.
Figure 6. ZNF274 binds to a gene containing multiple zinc finger domains. The number of finger domains in the C2H2 genes bound by
ZNF274 are shown (solid line), along with the number of finger domains found in all 712 C2H2 zinc finger genes encoded in the hg18 human genome
build (dotted line).
doi:10.1371/journal.pone.0015082.g006
Figure 7. A model for SETDB1 recruitment. Shown is a schematic
illustrating the current model for KAP1-mediated transcriptional
repression. KAP1 is thought to be brought to the genome by
interaction with a KRAB-ZNF, which binds site-specifically to DNA.
KAP1 in turn is thought to recruit the histone methyltransferase
SETDB1, which then specifically mediates trimethylation of lysine 9 of
histone H3 near the KRAB-ZNF binding sites.
doi:10.1371/journal.pone.0015082.g007
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Cell culture
Human chronic myelogenous leukemia cells (K562, ATCC #
CCL-243) and human lymphoblastoid cells (GM12878, Coriell
Catalog ID GM12878) were grown in RPMI supplemented with
10% FBS, 2 mM L-Glutamine, 100 U/mL Pen-Strep. Human
cervical carcinoma cells (HeLa-S3, ATCC CCL-2.2) and human
hepatocellular carcinoma (HepG2, ATCC # HB-8065) were
grown in Dulbecco’s modified Eagle’s medium supplemented with
10% FBS, 2 mM L-Glutamine, 100 U/mL Pen-Strep.
ChIP-chip assays
TRIM28 (KAP1), G9a, H3K9me3, and SETDB1 ChIP samples
using 10
7 K562 cells per ChIP were prepared as described at http://
www.genomecenter.ucdavis.edu/farnham/protocol.html with minor
modifications. ChIP assays were performed using 1.6 mg SETDB1
antibody (Proteintech Group #11231-1-AP), 5 mgG 9 aa n t i b o d y
(Upstate #07-551) or 2 mg TRIM28 (KAP1) antibody (Abcam
#ab10483). Two G9a ChIPs and three KAP1 ChIPs were pooled
and concentrated using speedvac before amplification. Prior to array
hybridization, TRIM28 (KAP1), SETDB1 and G9a ChIP DNA was
amplified using the Sigma GenomePlex WGA2 kit as described in
O’Geen et al. [56]. Briefly, the initial random fragmentation step is
omitted and DNA from the entire ChIP sample(s) or from 20 ng
input DNA is amplified. TRIM28 (KAP1) and SETDB1 amplicons
were confirmed by PCR using primers for ZNF333 as a positive
control and for hPolII as a negative control. Labelling of amplicons
and hybridization to chromosome tiling arrays were performed by
Roche NimbleGen. The HG18Tiling Set 9 HX1 of the NimbleGen
HD2platformwasused,whichcontainschromosomes17,18,and19
and parts of chromosomes 16 and 20 tiled at a 100 bp interval using
Figure 8. Depletion of ZNF274 inhibits KAP1 recruitment and H3K9 trimethylation at target genes. A) Control siRNAs or specific siRNAs
targeting ZNF274 were transfected into HelaS3 cells and western blot analysis of ZNF274 was performed; KAP1 and Actin antibodies were used as
loading control. B) Shown are the binding patterns of KAP1, SETDB1, ZNF274, and H3K9me3 on a ZNF274 target gene (ZNF554) and on a zinc finger
gene not bound by ZNF274 (ZNF556). C) Control siRNAs or specific siRNAs targeting ZNF274 were transfected into HelaS3 cells and ZNF274, KAP1,
SETDB1 and H3K9me3 chromatin immunoprecipitation (ChIP) analyses were performed. The fold change in occupancy of ZNF274, KAP1, SETDB1, and
H3K9me3 at the ZNF274 positive targets (ZNF180 and ZNF554) and negative sites (ZNF555 and ZNF556) for each factor was measured as the change in
the mean enrichment for that factor from experiments with siRNA against ZNF274 over control siRNAs.
doi:10.1371/journal.pone.0015082.g008
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data is MIAMEcompliant and the raw data has been deposited at the
MIAME compliant Gene Expression Omnibus (GEO) database at
National Center for Biotechnology Information (http://www.ncbi.
nlm.nih.gov/geo) and are accessible through accession number
GSE24480.
ChIP-chip peak calling: Oftentimes oligo intensities will
vary within a binding site due to lack of sensitivity in hybridization.
As a result, many ChIP-Chip peak-calling programs currently
available will not detect certain peaks, and perform poorly with
histone modification data. Therefore, in order to interpret our
data more accurately, we have developed a new ChIP-chip peak-
calling program,Mayacamas (available http://www.genomecenter.
ucdavis.edu/farnham/software.html). The data was first smoothed
using a sliding average: the values of five oligos on either side of a
center oligo are averaged to determine the new smoothed value of
the center oligo. Using the smoothed data, the top 5%, top 1% and
top .5% of oligos were determined. If adjacent oligos, spanning at
least 800 bp, were above threshold, the region was called a peak.
We accounted for the fact that ChIP-Chip arrays often lack
oligos in certain regions that are not unique by allowing for 6
or less missing oligos in a peak region. In order to eliminate
false positives produced by this, we also specified that a peak
region must include at least half of the number of expected
oligos. We used the peak cutoff of top 5% for H3me3K9 in
order to account for the spreading nature of histone marks. The
top 1% cutoff was used for KAP1 and SetDB1 experiments,
and the top .5% cutoff was used for G9a to eliminate false
positives since this factor does not have many binding sites.
CHIP-seq assays
For ChIP-seq, KAP1 and ZNF274 ChIP samples were prepared
from K562 cells as follows: cultures of 1610
8 K562 cells were
harvested at a density of 10
6 cells/mL and cross-linked with 1%
formaldehyde for 10 minutes at room temperature. Cross-linking
was stopped by the addition of glycine to 125 mM final
concentration and cells were washed twice with 16PBS. The cell
pellet was then resuspended in 2 mL ChIP lysis buffer (50 mM
Tris-Cl pH 8.0, 5 mM EDTA, 1% SDS, 1 complete protease
inhibitor tablet [Roche]) and incubated on ice for 30 minutes.
Samples were sonicated for 30 minutes, with 30-second pulses, 1
minute resting, using the Bioruptor sonicator (Diagenode) to
produce chromatin fragments of 0.5 kb on average. After
clarification by centrifugation, sonicated extracts were precleared
with 20 ml/10
7 StaphA cells blocked with 10 mg/mL BSA. The
precleared extracts were diluted 1:10 with ChIP dilution buffer
(1% triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-Cl
pH 8.0, 5 mM PMSF). Anti-ZNF274 antibody or anti-KAP1
antibody (Novus Biologicals, catalog # H00010782-A01 and
AbCam, catalog # ab3831, respectively) was added at a
concentration of 2 mg/10
7 cells and incubated for 12 hours at
4uC. A rabbit anti-mouse or rabbit anti-goat secondary antibody
was added at an equal concentration for 1 hour at 4uC.
Complexes were recovered with StaphA cells for 15 minutes at
room temperature and washed 5 times with ice cold RIPA buffer.
Precipitates were resuspended in 100 ml ChIP elution buffer (1%
SDS, 0.1 M NaHCO3), incubated at 65uC for 12 hours and
treated with 10 mg RNaseA for 20 minutes at 37uC. After pooling,
the DNA was recovered from the eluate using the QIAquick PCR
Figure 9. The H3K9me3 methylome. A) Schematic showing that the histone methytransferase SETDB1 is responsible for a large proportion, but
not all, of the H3K9me3 sites in K562 cells and that ZNF274 is responsible for recruiting SETDB1 to some, but not all, of the SETDB1 binding sites. B)
The distance of all H3K9me3 peaks found in the top 10% of that dataset is shown relative to the center of the nearest SETDB1 peak. C) Shown is the
binding pattern of SETDB1 and H3K9me3 for a region of chromosome 21, indicating that there are large regions of the genome covered by H3K9me3
but not by SETDB1.
doi:10.1371/journal.pone.0015082.g009
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instructions. For H3K9me3 ChIP-seq, chromatin was prepared
as above, except only 5610
6 K562 cells were used and 5 mg anti-
H3K9me3 antibody (Diagenode, catalog # pAb-056-050) was
added to the ChIP reactions. For SETDB1 ChIP-seq, ChIP
samples were prepared as for ZNF274 and KAP1 from 10
8 K562
cells, using 20 mg anti-SETDB1 antibodies (Proteintech Group,
catalog # 11231-1-AP), except chromatin was prepared using the
SimpleChIP
TM Enzymatic Chromatin IP Kit according to the
manufacturer’s recommendations (Cell Signaling Technology,
catalog # 9003). For ZNF274 ChIP-seq assays using HeLa,
GM12878 and HepG2 cells, the same conditions for K562 cells
were used. For ChIP assays using siRNA-transfected cells, HeLa
cells were transfected with siRNAs (see below) and chromatin was
prepared by sonication. Antibodies specific for ZNF274, KAP1,
SETDB1 and H3K9me3 were used at 1 ug/2.5610
5 cells. All
ChIP-seq data is deposited in the Gene Expression Omnibus
(GEO) database at National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov/geo) and are accessible through
accession number GSE24632.
ChIP-seq library construction and quantitation
ChIPlibraries werecreated as described previously [57], using 15
cycles of amplification. Libraries were run on a 2% agarose gel and
the 200-400 and 400-600 fractions of the library was extracted and
purified. To estimate the yield of library and its relative
amplification value,libraryDNAwasquantitated usinga Nanodrop
and serial dilutions of 1.25 nM library were compared to a
reference library by real-time PCR using primers complementaryto
the library adapters. In general, we have found that the400-600 size
libraries contain higher enrichments for heterochromatic regions
and for factors that bind to H3K9me3 (see Supplementary
Figure S3). The amplificationvalue relativeto the referencelibrary
was used to estimate the flowcell loading concentration. The ChIP-
seq libraries were run on an Illumina GA2 by the DNA
Technologies Core Faciity at the University of California-Davis
(http://genomecenter.ucdavis.edu/dna_technologies/).
ChIP-seq peakcalling
The Sole-search software was modified in order to more
accurately identify histone regions. Duplication and deletion
events were first determined in the input datasets and the
sequenced ChIP and background files were normalized accord-
ingly, as described in the original version [29]. In the new modified
version of Sole-search (described in Blahnik et al. in preparation),
both the ChIP-seq data and the background model are smoothed,
before determining a statistically significant peak height cutoff.
Data was binned using a sliding window of 30 bp. The value for
each bin was calculated as the mean of all values within 600 bp
upstream and 600 bp downstream of the bin. Statistically
significant height cutoff was determined as the lowest value not
surpassing a false discovery rate of 0.01. The final of the three steps
in Sole-search, significance over background, was removed
because small peaks in input data do not affect peak-calling when
analyzing ChIP-seq data composed of broad chromatin domains,
rendering this step unnecessary. Peaks were called if they exceeded
height cutoff and length cutoff. Minimum length was determined
as 150 bp, approximating the minimal chromatin fragment size
used in a library procedure.
Sequential ChIP assays
Crosslinked cell extracts were prepared from 2610
7 HeLa cells
as described above. The extracts were split into six separate ChIP
reactions, three for ZNF274 ChIPs and three for KAP1 ChIPs
using 2 mg antibody per reaction. The primary ChIP reactions
were incubated for 12 hours at 4uC, washed and eluted as
described above. The eluates were then diluted 1:10 with ChIP
dilution buffer for sequential ChIP reactions using 1 mg of the
indicated antibody. The sequential immunoprecipitations were
incubated for 6 hours at 4uC, washed five times with ice cold
RIPA buffer and eluted in 100 mL ChIP elution buffer. The eluted
DNA was purified using Qiagen PCR purification columns and
used for PCR reactions with 37 cycles of PCR.
Quantitative real-time PCR
Quantitative real-time PCR (qPCR) was performed on a Bio-
Rad DNA Engine Opticon Real-Time PCR System using SYBRH
Green Master PCR Mix according to the manufacturer’s
instructions (Invitrogen). The fold enrichment of each target site
was calculated as 2 to the power of the cycle threshold (cT)
difference between input chromatin and ChIP samples. All
primers are listed in Supplementary Table S5.
siRNA treatment
For ZNF274 knockdown RNA analysis, HeLa cells were
transfected with 40 nM ZNF274 siRNAs (Stealth Select RNAi;
Invitrogen, HSS116638;HSS116639;HSS116640) or si-GLO
RISC-Free (Dharmacon, cat# D-001600-01) as a non-specific
control using Invitrogen Lipofectamine2000 according to manu-
facture recommendations. Cells were transfected, retransfected
48 h later and harvested at 96 h following the initial transfection
for collection of RNA, protein or chromatin. RNA was prepared
using Invitrogen Trizol according to the manufacturer’s recom-
mendations; protein was extracted with ice-cold RIPA buffer
containing a protease inhibitor cocktail and chromatin was
prepared as described.
GST-KRAB domain purification
cDNA fragments encoding the KRAB domains of human
ZNF10 (residues 2-90), ZNF263 (residues 206-299) and ZNF274
(residues2-90 for KRAB1 and residues 278-366 for KRAB2) were
amplified by PCR and subcloned into the pGEX-SG vector. The
purification of recombinant GST-KRAB proteins was performed
using glutathione agarose beads according to the manufacturer’s
recommendations (Invitrogen). Briefly, Escherichia coli BL21 Star
cells (Invitrogen, catalog # C6010-03) bearing the plasmid were
propagated with aeration at 37uC in 250 mL of Luria broth to an
A600 of approximately 0.6. IPTG was added to 1 mM, and growth
at 37uC was continued for four hours. The cells were harvested by
centrifugation washed once with ice-cold PBS and resuspended in
phosphate buffered saline (PBS) supplemented with 0.1% Triton
X-100, 1 mM PMSF, 5 mM DTT, 100 mM MgCl2 and 0.5 mg/
ml lysozyme. The cell suspension was incubated for 1 hour at 4uC
with slow mixing. The suspension was then snap frozen and quick
thawed to lyse the cells. Following brief sonication, cell debris was
removed by centrifugation at 10 0006ga t4 uC for 30 min. The
supernatant was mixed with 0.2 mL glutathione agarose beads
(washed twice in PBS) and incubated for 1 hour at 4uC with gentle
mixing. The beads were pelleted and washed twice times with PBS
containing 0.1% Triton X-100 and 2 M NaCl, twice with PBS
containing 0.1% Triton X-100 and once in 10 mM Hepes-NaOH
(pH 7.9), 0.3 M KCl, 1.5 mM MgCl2, 0.5 mM PMSF and 0.1%
Triton X-100.
KAP1 interaction assay
Recombinant GST-KRAB domains or GST alone prebound to
glutathione-agarose beads in 10 mM Hepes-NaOH (pH 7.9), 0.3
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was incubated with undialyzed nuclear extracts for 4 hours at 4uC
prepared from 1610
7 K562 cells according to the method of
Dignam [58]. The glutathione-agarose beads were then washed 7
times with the same buffer containing 0.5 M KCl, and bound
proteins were eluted from the beads with 100 mM Tris-HCl
(pH 7.9), 0.12 M NaCl, 0.1%Triton X-100, and 20 mM gluta-
thione. The eluates were analyzed by 10% SDS-PAGE, and
proteins were visualized by coomassie staining and western
blotting with antibodies specific to KAP1.
Co-immunoprecipitation assays
A total of 2610
8 K562 cells were lysed in buffer A containing
20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2.5 mM EDTA, 0.5%
NP-40, 5% glycerol, 0.2 mM phenylmethylsulfonyl fluoride
(PMSF), and 0.5 mM dithiothreitol. Cell lysates were precleared
with protein G-agarose beads for 1 hour at 4uC and then
incubated with the indicated antibody for 5 hours at 4uC with
rotation at 5 mg of antibody per immunoprecipitation. The
reactions were precipitated with 40 mL protein G-agarose beads
for 1 hour at 4uC and then washed five times with lysis buffer and
eluted by boiling in sample buffer. The eluted proteins were
resolved on 10% SDS-PAGE gel electrophoresis for western
blotting analysis using the indicated antibodies.
RNA data analysis
Affymetrix Human Exon 1.0 ST (HuEx-1_0-st-v2) Arrays,
consisting of 1.4 million probe sets of clustering 1.0 million exon
clusters from .5,500,000 features, were used for measuring basal
level gene expression in K562 cells. A total of seven biological
samples from seven different institutions (from seven ENCODE
consortium groups) were performed on this array platform and the
generated quantified Affymetrix image files (seven *.CEL files)
were analyzed simultaneously and normalized using the RMA
algorithm provided in the Expression Console software developed
by Affymetrix Inc. Probe sets were annotated as supported by
RefSeq and full-length GenBank Transcripts, resulting in 21,924
annotated probe sets representing ,18,000 annotated genes. A
scale of LOG2 was used for calculating the abundance for each
probe set gene for each sample. The RNA expression array data
can be accessed through the NCBI Gene Expression Omnibus
database at National Center for Biotechnology Information
through the accession number GSE19146.
We computed a mean value of seven replicates for each gene on
the array as a final value of the gene’s expression level. We then
compared the expression levels of the ZNF274 target genes, as
identified using a location analysis program. We note because
most location analysis programs link a binding site with the nearest
transcription start site, we had to modify our location analysis
program to allow appropriate characterization of ZNF274 binding
sites. ZNF274 binds to the 39 exons of C2H2 zinc finger genes
and, due to the high density of genes on chromosome 19, the
binding site is in many cases closer to the start site of the
neighboring gene than it is to the start site of the gene to which the
exon belongs. Standard location analysis programs would
incorrectly identify ZNF274 binding sites as being in proximal
promoter regions, when in fact they are located in 39 exons.
Therefore, to identify the ‘‘nearest’’ gene to the ZNF274 binding
sites, our location analysis program was modified to first identify
binding sites within genes and then to look for the nearest gene for
those sites not found in the first pass. After obtaining the list of
genes nearest to ZNF274 binding sites, we determined their
expression level in K562 cells.
De novo motif analysis
To identify motifs enriched under ZNF274 binding sites from
the K562 ChIP-seq data, we first retrieved 100 nt from each of the
337 binding sites (50 nt on either side of the mid-point of the
peak). Then, we applied the de novo motif discovery approach
(ChIPMotifs) which can identify both known and novel motifs
[43,44]. Although the standard background data set for motif
finding is promoter regions, this was not appropriate for the
ZNF274 peak analysis. The ZFN274 peaks are all located within
the 39 coding exons of ZNF genes and, as such, all contain
common motifs such as finger domains and linker domains that
may be related to the coding potential of the exon and not to the
recruitment of ZNF274. Therefore, we used a set of ,90
sequences that represented 39 exons from ZNF genes that were
not bound by ZNF274 as the negative dataset. Using this
apprpoach, we identified a total of 28 motifs, none of which have
a significant match to any known motif in the TRANSFAC [59]
and JASPAR [60] databases. From the 28 identified motifs,
clusters of similar motifs were derived based on sequence similarity
(many of the shorter motifs were contained within longer motifs).
Supporting Information
Figure S1 Identification of G9a target sites in K562 cells using
tiling arrays. A. ChIP-chip analysis of G9a binding sites. B. PCR
analysis of G9a binding sites. Using separate biological ChIP
replicates, three G9a binding sites identified by ChIP-chip were
confirmed to be G9a, but not SETDB1, targets. In contrast, the
H3K9me3 target ZNF84 shows the presence of SETDB1, but not
G9a. As expected, the active MFAP promoter is not occupied by
either of the histone methyltransferases. Enrichments are shown in
comparison to total chromatin DNA; IgG was used as a negative
control.
(PDF)
Figure S2 Western blot and immunoprecipitation-western blot
validation of anti-ZNF274 antibody. A) Western blot using 30
ugnuclear extracts prepared from 4 human cell lines. B)
Immunoprecipitationof ZNF274 from HepG2 nuclear extracts
using control rabbit IgG and anti-ZNF274 mouse IgG. The signal
from the mouse anti-ZNF274 IgGis indicated.
(PDF)
Figure S3 qPCR analysis of ZNF274 ChIP-seq libraries
prepared from two different fractions. ZNF274 libraries were
prepared as described in the Materials and Methods section.
Following 14 cycles of PCR amplification and agarose gel
electrophoresis, two different sized fractions (200-400 bp and
400-600 bp) were excised and extracted and compared to a library
of input non-ChIP enriched DNA. The targets analyzed are
shown below and primer sequences are listed in the supplementary
information.
(PDF)
Figure S4 Enriched motifs found in ZNF274 binding sites. W-
ChIPMotifs was used to extract enriched motifs present in
ZNF274 binding sites as described in the Materials and Methods
section. Shown are the detected motifs with their SeqLOGOs,
PWMs, core and PWM scores, P-values and Bonferroni correction
P-value at different percentile levels for each identified motif.
(PDF)
Figure S5 The similarity of the ZNF274 enriched motifs is
compared to the closest known motif for other factors using the
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STAMP tool.
(PDF)
Figure S6 Comparison of peak sets identified using ChIP-chip
and ChIP-seq for H3K9me3, SETDB1, and KAP1. An example
of the binding patterns for H3K9me3, SETDB1, and KAP1 using
the different platforms is shown in panel A. The ChIP-chip vs.
ChIP-seq binding patterns for H3K9me3, for SETDB1, and
KAP1 are very similar. However, the ChIP-chip data has
considerably more background and the data is compressed into
a smaller range (such that it is difficult to distinguish the very
highest peaks from the moderately high peaks). For H3K9me3, we
identified 1497 ChIP-chip peaks and 3866 ChIP-seq peaks on
chromosome 19, and found that half of the H3K9me3 peaks from
obtained using one platform are represented in the dataset
obtained using the other platform (panel B); in general, these
common peaks are found in regions displaying the highest and
widest coverage by H3K9me3. The peaks that did not overlap
were narrower peaks that tended to be difficult to analyze in one of
the experimental platforms. For example, some regions were not
represented on the array because of the spacing of the
oligonucleotides and some regions were not represented in the
sequenced tags because they matched to more than one place on
the genome. We next compared the SETDB1 and KAP1 peak sets
obtained using ChIP-chip vs. ChIP-seq. Again, the ChIP-seq data
was much more robust, having higher signal to noise than the
ChIP-chip data. Most of the SETB1 (83%) and KAP1 (95%)
ChIP-seq peaks were contained within the ChIP-chip peak sets,
suggesting that the extra peaks in the ChIP-chip sets are false
positives.
(PDF)
Figure S7 Heatmap of expression data for ZNF274 targets. The
expression levels of the subset of ZNF274 target genes (identified
as the nearest gene to each binding site from the K562 ZNF274
ChIP-seq dataset) present on the Affymetrix Human Exon 1.0 ST
(HuEx-1_0-st-v2) Arrays is shown compared to the expression
levels of the same number of genes from each of the 5 quintiles
representing expression of all mRNAs in K562 cells.
(PDF)
Figure S8 Motifs identified inZNF274 binding sites. (A) Motifs
identified within 50 nucleotides of either side of the center of
ZNF274 binding sites. Also indicated is the number of occurrences
of each motif in the 337 ZNF274 binding sites identified in K562
cells. Both ZNF274M11 and ZNF274M1 are present in 72 of the
top 100 ranked ZNF274 binding sites from K562 cells. (B) The
overlap of the 59 end of the reverse orientation of the M1 motif
and the 39 end of the M11 motif. (C) The sequence of the full
29mer. (D) The reverse orientation of the 29mer encodes the
conserved linker and the conserved H2 helix found in C2H2 zinc
fingers.
(PDF)
Figure S9 ChIP-seq binding patterns of ZNF274, KAP1,
SETDB1, and H3K9me3 at individual gene loci. Shown are
snapshots of the ChIP-seq data at specific C2H2 ZNF genes.
(PDF)
Figure S10 Shown is a comparison of ZNF274 binding sites, the
location of all C2H2 ZNF genes, and the location of the identified
29mer motif (with 2 allowed mismatches) in forward and reverse
orientations across the right arm of chromosome 19. There is a
high correspondence between ZNF274 binding sites and the
subset of C2H2 ZNF genes that contain the 29mer motif.
(PDF)
Table S1 A summary of the ChIP-chip and ChIP-seq datasets
from this study.
(XLS)
Table S2 ChIP-chip peak sets for SETDB1, KAP1, H3K9me3,
and G9a.
(XLS)
Table S3 ChIP-seq peak sets for ZNF274 in the cell lines K562,
HeLa, HepG2, and GM12878.
(XLS)
Table S4 ZNF274 motif distribution.
(XLS)
Table S5 Primers used for this study.
(XLS)
Table S6 A list of the target genes for the top 10% of the
H3K9me3 peaks either containing SETDB1 peaks or not having a
SETDB1 peak. Also shown is the GO ontology analysis for
biological process for those target genes.
(XLS)
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